LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0045U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0045U.
Elevated code risk
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
3
High
50%
3
Routine
50%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
LCD L36947: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) — Noridian
Policy LCD-L36947 · Oncology
New billing guidelines for Oncotype DX® can impact reimbursement.
LCD L36941: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) — Noridian
Policy LCD-L36941 · Oncology
compliance updates for Oncotype DX® starting 02/05/2026
LCD L37199: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) — WPS
Policy LCD-L37199 · Oncology
Prepare for billing changes with Oncotype DX® update.
Audit documentation
Building an audit file that includes 0045U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription